Anti-tumor and anti-metastatic roles of cordycepin, one bioactive compound of Cordyceps militaris

被引:70
作者
Jin, Ye [1 ]
Meng, Xue [1 ]
Qiu, Zhidong [1 ]
Su, Yanping [2 ]
Yu, Peng [1 ]
Qu, Peng [3 ]
机构
[1] Changchun Univ Chinese Med, Dept Pharm, 1035 Boshuo Rd, Changchun 130117, Jilin, Peoples R China
[2] Taishan Med Coll, Dept Histol & Embryol, Tai An, Shandong, Peoples R China
[3] NCI, NIH, Frederick, MD 21702 USA
基金
中国国家自然科学基金;
关键词
Cordycepin; Anti-tumor; Anti-metastasis; GALLBLADDER CANCER-CELLS; STEM-CELLS; APOPTOSIS; METASTASIS; MELANOMA; INVASION; PATHWAY; ARREST; CYCLE; ANGIOGENESIS;
D O I
10.1016/j.sjbs.2018.05.016
中图分类号
Q [生物科学];
学科分类号
07 ; 0710 ; 09 ;
摘要
Public interest in complementary and alternative medicine has been increased worldwide, due to its wide applications in cancer prevention and treatment. Cordycepin is one of the most common and crucial types of complementary and alternative medicine. Cordycepin (3'-deoxyadenosine), a derivative of adenosine, was first isolated from medicine drug Cordyceps militaris. Cordycepin has been widely used as one compound for antitumor, which has been found to exert antiangiogenic, anti-metastatic, and antiproliferative effects, as well as inducing apoptosis. However, the mechanism of its anti-tumor activity is not well known. This review will clarify anti-tumor mechanisms of Cordycepin, which regulate signaling pathways related with tumor growth and metastasis. Cordycepin inhibit tumor growth via upregulating tumor apoptosis, inducing cell cycle arrest and targeting cancer stem cells (CSCs). Cordycepin regulates tumor microenvironment via suppressing tumor metastasis-related pathways. Thus, Cordycepins may be one of important supplement or substitute medicine drug for cancer treatment. Production and hosting by Elsevier B.V. on behalf of King Saud University. This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).
引用
收藏
页码:991 / 995
页数:5
相关论文
共 59 条
  • [1] Cell cycle regulation and anticancer drug discovery
    Bai, Jingwen
    Li, Yaochen
    Zhang, Guojun
    [J]. CANCER BIOLOGY & MEDICINE, 2017, 14 (04) : 348 - 362
  • [2] Cancer stem cells revisited
    Batlle, Eduard
    Clevers, Hans
    [J]. NATURE MEDICINE, 2017, 23 (10) : 1124 - 1134
  • [3] The TOR pathway: A target for cancer therapy
    Bjornsti, MA
    Houghton, PJ
    [J]. NATURE REVIEWS CANCER, 2004, 4 (05) : 335 - 348
  • [4] Cordycepin induces apoptosis in human bladder cancer cells via activation of A3 adenosine receptors
    Cao, Hong-Li
    Liu, Zi-Jin
    Chang, Zheng
    [J]. TUMOR BIOLOGY, 2017, 39 (07) : 1 - 6
  • [5] Angiogenesis in cancer and other diseases
    Carmeliet, P
    Jain, RK
    [J]. NATURE, 2000, 407 (6801) : 249 - 257
  • [6] Molecular mechanisms and clinical applications of angiogenesis
    Carmeliet, Peter
    Jain, Rakesh K.
    [J]. NATURE, 2011, 473 (7347) : 298 - 307
  • [7] RNA-directed agent, cordycepin, induces cell death in multiple myeloma cells
    Chen, Lisa S.
    Stellrecht, Christine M.
    Gandhi, Varsha
    [J]. BRITISH JOURNAL OF HAEMATOLOGY, 2008, 140 (06) : 682 - 691
  • [8] The inhibitory effect of Cordycepin on the proliferation of cisplatin-resistant A549 lung cancer cells
    Cho, Seong Hyeok
    Kang, In-Cheol
    [J]. BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS, 2018, 498 (03) : 431 - 436
  • [9] CORDYCEPIN, A METABOLIC PRODUCT ISOLATED FROM CULTURES OF CORDYCEPS-MILITARIS (LINN) LINK
    CUNNINGHAM, KG
    MANSON, W
    SPRING, FS
    HUTCHINSON, SA
    [J]. NATURE, 1950, 166 (4231) : 949 - 949
  • [10] Proliferation, cell cycle and apoptosis in cancer
    Evan, GI
    Vousden, KH
    [J]. NATURE, 2001, 411 (6835) : 342 - 348